Kazuhito Suzuki
- Hematology top 10%
- Multiple Myeloma Research and Treatments 31
-
- Peptidase Inhibition and Analysis 12
- Cancer Treatment and Pharmacology 5
-
- Protein Degradation and Inhibitors 19
-
- Lymphoma Diagnosis and Treatment 10
-
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- CNS Lymphoma Diagnosis and Treatment 4
Kazuhito Suzuki
51 papers receiving 375 citations
Peers
Comparison fields: 5 of 50
- Hematology 100
- Radiology, Nuclear Medicine and Imaging 166
- Cardiology and Cardiovascular Medicine 148
- Surgery 183
- Oncology 109
Countries citing papers authored by Kazuhito Suzuki
This map shows the geographic impact of Kazuhito Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhito Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhito Suzuki more than expected).
Fields of papers citing papers by Kazuhito Suzuki
This network shows the impact of papers produced by Kazuhito Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhito Suzuki. The network helps show where Kazuhito Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuhito Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 18 | |
| 16 | 2020 | 1 | |
| 17 | 2014 | 6 | |
| 18 | 2012 | 8 | |
| 19 | 2011 | 2 | |
| 20 | 1999 | 6 |
About Kazuhito Suzuki
Kazuhito Suzuki is a scholar working on Hematology, Genetics and Oncology, having authored 62 papers that have together received 396 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (19 papers), Peptidase Inhibition and Analysis (12 papers), Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Treatment and Pharmacology (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (100 citations), Radiology, Nuclear Medicine and Imaging (166 citations) and Cardiology and Cardiovascular Medicine (148 citations). Kazuhito Suzuki has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Yasuhiro Ishii, Hiroshi Kasanuki, Yukio Tsurumi, Atsushi Takagi, Masatoshi Kawana, Shingo Yano, Kaichi Nishiwaki, Tomonori Nakazato, Keisuke Aiba and Yuko Mishima. Their work appears in journals such as International Journal of Hematology, Cancers, Journal of Clinical Oncology, Blood and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.